Contact
Please use this form to send email to PR contact of this press release:
CytomX Selects Probody Drug Conjugate Clinical Candidate, CX-2009, Targeting Highly Expressed Tumor Antigen, CD166
TO:
Please use this form to send email to PR contact of this press release:
CytomX Selects Probody Drug Conjugate Clinical Candidate, CX-2009, Targeting Highly Expressed Tumor Antigen, CD166
TO: